Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsDr. Reshma Kewalramani is recorded as CEO at Vertex Pharmaceuticals Inc (VRTX) since April 1, 2020. Dr. Reshma Kewalramani has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Vertex Pharmaceuticals Inc on November 2, 2026. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman), Jeffrey Leiden (Chairman and Board Member) and 7 others.
“I'm pleased to note that Vertex achieved another quarter of excellent commercial results and pipeline advancement. Third quarter, total revenue grew 12% year-on-year.”
“First of all, it's very nice to be here with you, Salveen. I know we're the last fireside chat, so it's good to see those of you in the room. I've described 2026 and for the next 6, 12, 18 months as a year or period of time for Vertex.”
“Vertex is in a somewhat different position than many other companies simply by virtue of our size and what we do. and maybe the thumbnail is that we're reasonably insulated from what has been going on with regard to MFN and some of the work with the larger companies.”
2020-04-01–present
Biotechnology · Healthcare
CEO
2020-04-01–present
